Ascendis Pharma sets third-quarter financial results release

ASND•2026-11-05

Ascendis Pharma will report third-quarter 2026 results and provide a business update on Nov. 12, 2026, before U.S. markets open. A conference call and live webcast will follow at 8 a.m. ET.

1. Results and webcast

Ascendis Pharma will report third-quarter 2026 results and provide a business update on Nov. 12, 2026, before U.S. markets open. A conference call and live webcast to discuss the results and update will follow at 8 a.m. ET.

Ascendis Pharma sets third-quarter financial results release

1. Results and webcast

Related News

nCino CEO and President Sean Desmond reports disposal of $932,961.48 in common shares

Equillium plans participation in Stifel, Jefferies healthcare conferences

Applied Optoelectronics Q3 2026 swings to $6.3 million net profit year-on-year

EverCommerce forecasts 2026 revenue of approximately $600 million

CVRx Q3 revenue falls on lower sales force productivity; cuts 2026 outlook